Lobbying Relationship

Client

Celgene Corporation

More records

Lobbying firm

Ernst & Young LLP (Washington Council Ernst & Young)

More records

  • FDA Reauthorization Act - HR 2430;HR 2212/S 974 - CREATES Act; HR 2051 - FAST Generics Act

Duration: to

General Issues: Health Issues

Spending: about $500,000 (But it's complicated. Here's why.)

Agencies lobbied since 2015: U.S. Senate, House of Representatives

Bills mentioned

H.R.2430: FDA Reauthorization Act of 2017

Sponsor: Greg Walden (R-Ore.)

H.R.2212: CREATES Act of 2017

Sponsor: Tom Marino (R-Pa.)

S.974: Creating and Restoring Equal Access to Equivalent Samples Act of 2018

Sponsor: Patrick J. Leahy (D-Vt.)

H.R.2051: FAST Generics Act of 2017

Sponsor: David McKinley (R-W.Va.)

H.R.1409: Cancer Drug Parity Act of 2017

Sponsor: Leonard Lance (R-N.J.)

S.1566: Cancer Drug Coverage Parity Act of 2015

Sponsor: Mark Steven Kirk (R-Ill.)

H.R.2739: Cancer Drug Coverage Parity Act of 2015

Sponsor: Leonard Lance (R-N.J.)

S.3056: CREATES Act of 2016

Sponsor: Patrick J. Leahy (D-Vt.)

H.R.2841: FAST Generics Act of 2015

Sponsor: Steve Stivers (R-Ohio)

H.R.6: 21st Century Cures Act

Sponsor: Fred Upton (R-Mich.)

H.R.34: 21st Century Cures Act

Sponsor: Suzanne Bonamici (D-Ore.)

Show All Mentioned Bills

Lobbyists

Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.

Lobbyist Covered positions?
Sarah Kuehl Egge 97Intern/98-00 LA Sen Kerrey;01-12 Sen Budget Cm;11 Def Red
Amy Jensen Cunniffe 99-01 Assistant to the Speaker for Policy; 03-05 Special Assistant to the President for Legislative Affairs
Heather Meade 00-02 Deputy Scheduler/Assistant to CoS, Senator Patty Murray
Stephen Adam Francis 96-00 LD to Rep. John Kasich; 01-11 Deputy CoS to Rep. Tiberi
Sarah Egge n/a

Disclosures Filed

Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.

Termination
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Registration

Source: Clerk of the U.S. House of Representatives and Secretary of the Senate

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print Google News logo Google_NewsInitiative_Lockup_FullColor RSS Search Search Twitter WhatsApp Resolving differences Check Building Arrow right Info circle Oops OOPS Pencil File text Bars Search Close Cogs Filter Compare Revolving Door Info card Activity Member menu Globe Document External link Quote News Calendar No Vote
Current site Current page